Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canopy Growth Corp (CGC) vs NetEase Inc (NTES) Price & Performance

Canopy Growth CorpTrade
NetEase IncTrade

Price performance (Past 24H)

Key statistics

Canopy Growth Corp vs NetEase Inc — how do they compare? Canopy Growth Corp trades at $1.02 (market cap $421.10M), while NetEase Inc trades at $123.7 (market cap $82.75B). The key difference: NetEase Inc is far larger — about 196.5× Canopy Growth Corp's market cap, and NetEase Inc pays a 2.36% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.

CGCNTES
Market Cap
$421.10M$82.75B
Sector
HealthMedia
52-Week High
$1.92$159.34
52-Week Low
$0.86$109.26
Enterprise Value
$378.55M$59.05B
Dividend Yield
2.36%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canopy Growth Corp

CGC trades at $0.95, down 1.86% in the last session, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year, beating estimates, but continues to post net losses. Recent news highlights expansion in European cannabis markets and cost-cutting efforts, while the stock remains volatile amid regulatory uncertainty.

Outlook is cautious due to persistent losses and high debt, though improving cash flow and revenue growth offer potential upside. Key risks include regulatory delays in U.S. cannabis rescheduling and competitive pressures. Investors should weigh the speculative nature against any positive regulatory catalysts.

NetEase Inc

NetEase (NTES) trades at $133.41, up 0.9% with bullish technical signals and strong fundamentals. The stock shows robust profitability with 29.84% net margins and 22.12% ROE, supported by consistent revenue growth to $112.63B in 2025. Recent Q1 2026 earnings beat expectations at $2.53 EPS versus $2.19 forecast. Technical analysis indicates bullish momentum with support at $131 and resistance at $135, while analyst consensus remains strongly positive with 82% buy ratings.

Outlook remains favorable given strong cash flow generation ($50.74B operating cash flow) and international expansion potential. Key risks include Chinese regulatory environment and competitive pressures. With attractive valuation at 16.31 P/E and bullish institutional sentiment, NTES presents growth opportunity though investors should monitor earnings consistency and market volatility.

Returns comparison

Trailing returns across standard periods

About Canopy Growth Corp

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more on CGC

About NetEase Inc

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

Read more on NTES